CorMedix Inc.

CRMD

$9.98

Name : CorMedix Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $786,314,688.00

EPSttm : 2.21

CorMedix Inc.

$9.98

11.21%

$1.26

Float Short %

22.92

Margin Of Safety %

Put/Call OI Ratio

0.38

EPS Next Q Diff

EPS Last/This Y

2.35

EPS This/Next Y

0.38

Price

9.97

Target Price

Analyst Recom

Performance Q

-23.58

Relative Volume

1.67

Beta

1.31

Ticker: CRMD

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	CRMD	12.16	0.39	0.44	48028
2025-10-21	CRMD	11.65	0.41	0.06	53270
2025-10-22	CRMD	11.21	0.39	0.70	55300
2025-10-23	CRMD	11.31	0.39	0.18	56388
2025-10-24	CRMD	11.16	0.39	0.22	57512
2025-10-27	CRMD	11.05	0.39	0.11	58295
2025-10-28	CRMD	11.13	0.38	0.24	59880
2025-10-29	CRMD	11.3	0.37	0.07	60971
2025-10-30	CRMD	11.61	0.37	0.18	61458
2025-10-31	CRMD	11.12	0.37	0.31	62386
2025-11-03	CRMD	11.54	0.38	0.20	62840
2025-11-04	CRMD	11.41	0.38	0.02	63109
2025-11-05	CRMD	11.16	0.38	0.13	63082
2025-11-06	CRMD	10.76	0.39	0.19	62699
2025-11-07	CRMD	10.78	0.38	0.06	63425
2025-11-10	CRMD	11.07	0.38	0.18	63906
2025-11-11	CRMD	11.19	0.38	0.37	65062
2025-11-12	CRMD	11.43	0.38	0.19	66357
2025-11-13	CRMD	11.22	0.38	0.15	66814
2025-11-14	CRMD	11.23	0.38	0.37	66603
2025-11-17	CRMD	9.98	0.38	0.32	66383
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	CRMD	12.16	974.3	-	1.79
2025-10-21	CRMD	11.65	974.3	-	1.79
2025-10-22	CRMD	11.20	974.3	-	1.74
2025-10-23	CRMD	11.30	974.3	-	1.74
2025-10-24	CRMD	11.15	1368.6	-	2.08
2025-10-27	CRMD	11.06	1368.6	-	2.08
2025-10-28	CRMD	11.14	1368.6	-	2.08
2025-10-29	CRMD	11.31	1368.6	-	2.08
2025-10-30	CRMD	11.62	1368.6	-	2.08
2025-10-31	CRMD	11.13	1368.6	-	2.08
2025-11-03	CRMD	11.53	1368.6	-	2.08
2025-11-04	CRMD	11.40	1368.6	-	2.08
2025-11-05	CRMD	11.16	1368.6	-	2.08
2025-11-06	CRMD	10.76	1368.6	-	2.08
2025-11-07	CRMD	10.76	1368.6	-	2.08
2025-11-10	CRMD	11.08	1368.6	-	2.08
2025-11-11	CRMD	11.19	1368.6	-	2.08
2025-11-12	CRMD	11.44	1368.6	-	2.08
2025-11-13	CRMD	11.22	1368.6	-	2.08
2025-11-14	CRMD	11.25	270.0	-	2.05
2025-11-17	CRMD	9.97	270.0	-	2.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	CRMD	-1.98	18.88	22.17
2025-10-21	CRMD	-1.98	18.88	22.17
2025-10-22	CRMD	-1.98	18.88	22.17
2025-10-23	CRMD	-1.98	18.88	22.17
2025-10-24	CRMD	-1.98	18.88	22.17
2025-10-27	CRMD	-1.98	18.91	23.05
2025-10-28	CRMD	-1.68	18.91	23.05
2025-10-29	CRMD	-1.67	18.91	23.06
2025-10-30	CRMD	-1.67	18.91	23.06
2025-10-31	CRMD	-1.67	18.91	23.06
2025-11-03	CRMD	-1.67	18.22	23.06
2025-11-04	CRMD	-1.67	18.22	23.06
2025-11-05	CRMD	-1.67	18.22	23.06
2025-11-06	CRMD	-1.67	18.22	23.06
2025-11-07	CRMD	-1.67	18.22	23.06
2025-11-10	CRMD	-1.67	18.00	23.06
2025-11-11	CRMD	-1.67	18.00	23.06
2025-11-12	CRMD	-1.67	18.00	23.66
2025-11-13	CRMD	-1.67	18.00	23.66
2025-11-14	CRMD	-1.67	18.00	23.05
2025-11-17	CRMD	-2.13	19.51	22.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.57

Avg. EPS Est. Current Quarter

0.81

Avg. EPS Est. Next Quarter

Insider Transactions

-2.13

Institutional Transactions

19.51

Beta

1.31

Average Sales Estimate Current Quarter

127

Average Sales Estimate Next Quarter

127

Fair Value

14.84

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-84.5

Target Price

P/E

4.86

Forward P/E

4.04

PEG

P/S

3.67

P/B

2.09

P/Free Cash Flow

10.57

EPS

2.05

Average EPS Est. Cur. Y

2.05

EPS Next Y. (Est.)

2.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

75.83

Relative Volume

1.67

Return on Equity vs Sector %

16.5

Return on Equity vs Industry %

31.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.26

EBIT Estimation

CorMedix Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 64

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

stock quote shares CRMD – CorMedix Inc. Stock Price stock today

news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRMD – CorMedix Inc. yahoo finance google finance

stock history CRMD – CorMedix Inc. invest stock market

stock prices CRMD premarket after hours

ticker CRMD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CRMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y